Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Leukemia, Myeloid, Acute 272Leukemia 194Precursor Cell Lymphoblastic Leukemia-Lymphoma 131Lymphoma 108Congenital Abnormalities 68Myelodysplastic Syndromes 63Leukemia, Myelomonocytic, Acute 60Leukemia, Monocytic, Acute 58Leukemia, Erythroblastic, Acute 56Leukemia, Megakaryoblastic, Acute 54Lymphoma, Non-Hodgkin 51Burkitt Lymphoma 44Lymphoma, Mantle-Cell 42Lymphoma, Large B-Cell, Diffuse 41Lymphoma, Follicular 33Leukemia, Myelomonocytic, Chronic 28Anemia, Refractory, with Excess of Blasts 27Hodgkin Disease 26Recurrence 25Lymphoma, Large-Cell, Immunoblastic 25Leukemia, Lymphocytic, Chronic, B-Cell 25Blast Crisis 24Leukemia, Eosinophilic, Acute 19Leukemia, Myelogenous, Chronic, BCR-ABL Positive 18Myeloproliferative Disorders 17Leukemia, Basophilic, Acute 17Lymphoma, B-Cell, Marginal Zone 16Leukemia, Promyelocytic, Acute 16Leukemia, Myeloid, Chronic-Phase 15Leukemia, Myeloid, Accelerated Phase 14

Interventions

Etoposide 2Cyclophosphamide 2prednylidene 1fialuridine 1deltacortene 1Vorinostat 1Vincristine 1Salvia hispanica seed extract 1Rituximab 1Prednisone 1Peripheral Blood Stem Cell Transplantation 1Granulocyte Colony-Stimulating Factor 1Filgrastim 1Doxorubicin 1Cytarabine 1Carmustine 1CT-P10 1Bone Marrow Transplantation 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Lymphoma, Primary Effusion × Cytarabine × Clear all
NCT00345865 2020-07-14

Autologous Peripheral Stem Cell Transplant in Treating Patients With Non-Hodgkin's Lymphoma or Hodgkin's Lymphoma

Masonic Cancer Center, University of Minnesota

Phase 2 Completed
473 enrolled 16 charts
Lymphoid

Hodgkin Disease, Lymphoma, Lymphoma, Non-Hodgkin, Lymphoma, Primary Effusion

Data powered by HemOnc (CC BY 4.0) Colophon âš¡